Naringin attenuates angiotensin II induced cardiac hypertrophy by inhibiting carbonic anhydrase II

Naringin attenuates angiotensin II induced cardiac hypertrophy by inhibiting carbonic anhydrase II

Abstract Nutraceuticals exert a series of health benefits, including protection against cardiovascular diseases. In this study, naringin, naringenin, and quercetin were tested for their safety and efficacy in ameliorating angiotensin (Ang) II-induced cardiac hypertrophy through carbonic anhydrase II...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahendra Mahadevaswamy, G. P. Suchitha, S. R. Pavan, H. K. Vivek, S. D. Nithya, S. Chandan, Shashanka K. Prasad, T. S. Keshava Prasad, Sheikh F. Ahmad, Sabry M. Attia, Shobha Dagamajalu, Jalahalli M. Siddesha
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Cardiac hypertrophy
NCX1
NHE1
CA-II
Nutraceuticals
Naringin
Online Access:https://doi.org/10.1038/s41598-025-95537-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items